Paul Kusserow's guest appearances

Paul Kusserow

Disrupt

A Second Opinion with Senator Bill Frist, M.D.

House Calls

B-Time with Beth Bierbower

Glen Tullman

Marty Makary

Patrick Quigley

Aaron Gani

Dan Trigub

Larry King

Keith Jones

Erik Larson

Mario Schlosser

Ed Catmull

Alexander Hamilton

Mark Hyman

Keith Smith

Matthew McConaughey

Dean Ornish

OwlTail

The desire for elderly people or individuals with life-threatening conditions to remain in their homes for as long as possible without being a burden to their families is strong.  Home is the future of healthcare and looking at recent acquisitions over the last 12 – 24 months, the race to deliver care in the home is on.    Today’s guest had a vision for providing care in the home long before many others.  Paul Kusserow, Chairman and CEO of Amedisys, a company that helps individuals remain in their homes through home health, personal care and hospice services.  Paul has served in senior executive roles at companies such as Humana, The Advisory Board, Zeigler, McKinsey and Tenet to name a few.  Paul is one of the best strategic thinkers in the industry, who can also execute on a strategy. Show Notes: Paul is rereading Plato as he believes the saying, “If you want to understand how the world works then read Plato.”; The Loyalty Effect by Frederick Reichheld, The Discipline of Market Leaders by Michael Treacy; The Checklist Manifesto by Atul Gawande

The desire for elderly people or individuals with life-threatening conditions to remain in their homes for as long as possible without being a burden to their families is strong.  Home is the future of healthcare and looking at recent acquisitions over the last 12 – 24 months, the race to deliver care in the home is on.  Today’s guest had a vision for providing care in the home long before many others.  Paul Kusserow, Chairman and CEO of Amedisys, a company that helps individuals remain in their homes through home health, personal care and hospice services.  Paul has served in senior executive roles at companies such as Humana, The Advisory Board, Zeigler, McKinsey and Tenet to name a few.  Paul is one of the best strategic thinkers in the industry, who can also execute on a strategy. Show Notes: Paul is rereading Plato as he believes the saying, “If you want to understand how the world works then read Plato.”; The Loyalty Effect by Frederick Reichheld, The Discipline of Market Leaders by Michael Treacy; The Checklist Manifesto by Atul Gawande

The future of Home Care Delivery with Amedisys Chairman & CEO Paul Kusserow

Paul Kusserow is the Chief Executive Officer and Chairman of the Board of Amedisys, a publicly traded, leading provider of home health, hospice, palliative and personal care services with over 22,000 employees in 39 states and Washington, DC, making over 12.3 million patient visits per year. Under his leadership, the company has grown its value 9-times itself and has been established as a clinical leader in the fast-growing home health and hospice industry. You’ll want to hear how Paul completely revamped his board to mirror his employees and the patients he’s serving, and why the biggest career risk he’s ever taken changed his life.

Paul Kusserow is the Chief Executive Officer and Chairman of the Board of Amedisys, a publicly traded, leading provider of home health, hospice, palliative and personal care services with over 22,000 employees in 39 states and Washington, DC, making over 12.3 million patient visits per year. Under his leadership, the company has grown its value 9-times itself and has been established as a clinical leader in the fast-growing home health and hospice industry. You’ll want to hear how Paul completely revamped his board to mirror his employees and the patients he’s serving, and why the biggest career risk he’s ever taken changed his life.

125 - Paul Kusserow, Chairman & CEO of Amedisys – Leading a turnaround, to stabilization, to record growth

Since joining Amedisys (Nasdaq: AMED) in 2014, CEO Paul Kusserow has spearheaded an ambitious turnaround effort, during which time the company’s stock has climbed from around $20 per share to the more than $130 per share range it sits at today.Most of Amedisys’ growth over the years has come organically, though the Baton Rouge, Louisiana-based company has been active on the M&amp;A front as well, reflected by its two recent hospice deals.Listen to this episode of Disrupt to learn:- What Amedisys is doing to prepare for PDGM- How the company has grown over the last four years- Why Amedisys is becoming an even bigger hospice player- …And much more!

Since joining Amedisys (Nasdaq: AMED) in 2014, CEO Paul Kusserow has spearheaded an ambitious turnaround effort, during which time the company’s stock has climbed from around $20 per share to the more than $130 per share range it sits at today. Most of Amedisys’ growth over the years has come organically, though the Baton Rouge, Louisiana-based company has been active on the M&amp;A front as well, reflected by its two recent hospice deals. Listen to this episode of Disrupt to learn: - What Amedisys is doing to prepare for PDGM - How the company has grown over the last four years - Why Amedisys is becoming an even bigger hospice player - …And much more!

Amedisys CEO Paul Kusserow